vs
HBT Financial, Inc.（HBT）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是HBT Financial, Inc.的1.0倍（$69.8M vs $67.3M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 16.6%，领先367.4%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 9.0%）
HBT Financial, Inc.是总部位于美国伊利诺伊州的区域性银行控股公司，主要为运营区域内的社区居民、中小微企业提供各类零售及商业银行业务，涵盖存取款服务、消费及商业信贷、财富管理咨询、按揭贷款等金融产品。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
HBT vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.0倍
$67.3M
净利率更高
RIGL
高出367.4%
16.6%
两年增速更快
RIGL
近两年复合增速
9.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $67.3M | $69.8M |
| 净利润 | $11.2M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | 16.6% | 384.0% |
| 营收同比 | — | 21.2% |
| 净利润同比 | -41.3% | 1769.2% |
| 每股收益（稀释后） | $0.34 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HBTRIGL
| Q1 26 | $67.3M | — | ||
| Q4 25 | $60.4M | $69.8M | ||
| Q3 25 | $59.8M | $69.5M | ||
| Q2 25 | $58.8M | $101.7M | ||
| Q1 25 | $58.0M | $53.3M | ||
| Q4 24 | $59.0M | $57.6M | ||
| Q3 24 | $56.4M | $55.3M | ||
| Q2 24 | $56.6M | $36.8M |
净利润HBTRIGL
| Q1 26 | $11.2M | — | ||
| Q4 25 | — | $268.1M | ||
| Q3 25 | $19.8M | $27.9M | ||
| Q2 25 | $19.2M | $59.6M | ||
| Q1 25 | $19.1M | $11.4M | ||
| Q4 24 | $20.3M | $14.3M | ||
| Q3 24 | $18.2M | $12.4M | ||
| Q2 24 | $18.1M | $-1.0M |
毛利率HBTRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% |
营业利润率HBTRIGL
| Q1 26 | — | — | ||
| Q4 25 | 42.9% | 33.2% | ||
| Q3 25 | 44.7% | 40.9% | ||
| Q2 25 | 44.8% | 60.1% | ||
| Q1 25 | 44.0% | 23.9% | ||
| Q4 24 | 46.4% | 28.9% | ||
| Q3 24 | 43.4% | 25.4% | ||
| Q2 24 | 44.1% | 1.2% |
净利率HBTRIGL
| Q1 26 | 16.6% | — | ||
| Q4 25 | — | 384.0% | ||
| Q3 25 | 33.0% | 40.2% | ||
| Q2 25 | 32.7% | 58.6% | ||
| Q1 25 | 32.9% | 21.5% | ||
| Q4 24 | 42.8% | 24.9% | ||
| Q3 24 | 32.2% | 22.5% | ||
| Q2 24 | 31.9% | -2.8% |
每股收益（稀释后）HBTRIGL
| Q1 26 | $0.34 | — | ||
| Q4 25 | $0.60 | $14.11 | ||
| Q3 25 | $0.63 | $1.46 | ||
| Q2 25 | $0.61 | $3.28 | ||
| Q1 25 | $0.60 | $0.63 | ||
| Q4 24 | $0.64 | $0.82 | ||
| Q3 24 | $0.57 | $0.70 | ||
| Q2 24 | $0.57 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $287.7M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $747.4M | $391.5M |
| 总资产 | $6.8B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资HBTRIGL
| Q1 26 | $287.7M | — | ||
| Q4 25 | $122.3M | $155.0M | ||
| Q3 25 | $155.1M | $137.1M | ||
| Q2 25 | $195.7M | $108.4M | ||
| Q1 25 | $211.6M | $77.1M | ||
| Q4 24 | $137.7M | $77.3M | ||
| Q3 24 | $179.7M | $61.1M | ||
| Q2 24 | $195.2M | $49.1M |
总债务HBTRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M |
股东权益HBTRIGL
| Q1 26 | $747.4M | — | ||
| Q4 25 | $615.5M | $391.5M | ||
| Q3 25 | $599.1M | $117.6M | ||
| Q2 25 | $580.9M | $81.9M | ||
| Q1 25 | $565.1M | $18.6M | ||
| Q4 24 | $544.6M | $3.3M | ||
| Q3 24 | $537.7M | $-14.6M | ||
| Q2 24 | $509.5M | $-29.9M |
总资产HBTRIGL
| Q1 26 | $6.8B | — | ||
| Q4 25 | $5.1B | $513.6M | ||
| Q3 25 | $5.0B | $242.5M | ||
| Q2 25 | $5.0B | $206.7M | ||
| Q1 25 | $5.1B | $176.0M | ||
| Q4 24 | $5.0B | $164.0M | ||
| Q3 24 | $5.0B | $139.4M | ||
| Q2 24 | $5.0B | $128.4M |
负债/权益比HBTRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流HBTRIGL
| Q1 26 | — | — | ||
| Q4 25 | $85.1M | $22.0M | ||
| Q3 25 | $17.2M | $24.0M | ||
| Q2 25 | $13.6M | $30.5M | ||
| Q1 25 | $30.4M | $-893.0K | ||
| Q4 24 | $89.4M | $14.5M | ||
| Q3 24 | $25.5M | $21.7M | ||
| Q2 24 | $19.8M | $302.0K |
现金转化率HBTRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | 0.87× | 0.86× | ||
| Q2 25 | 0.70× | 0.51× | ||
| Q1 25 | 1.60× | -0.08× | ||
| Q4 24 | 4.41× | 1.01× | ||
| Q3 24 | 1.40× | 1.75× | ||
| Q2 24 | 1.10× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HBT
| Net Interest Income | $56.4M | 84% |
| Noninterest Income | $10.9M | 16% |
RIGL
暂无分部数据
